Home 2025

Archives

Metastatic papillary thyroid carcinoma (cancer), central lymph node.

Cancer care through molecular diagnostics: Addressing papillary thyroid cancer

Oliver Bathe from the University of Calgary and Qualisure Diagnostics, walks us through addressing the surge in papillary thyroid cancer incidence by refining cancer care through molecular diagnostics.

The Cumming School of Medicine

The Cumming School of Medicine (CSM) at the University of Calgary is a leading Canadian medical institution renowned for its innovative education, research, and commitment to health equity.
Doctor with human thyroid anatomy model. Thyroid tumor and cancer, postpartum period, papillary carcinoma and health

Rethinking papillary thyroid cancer: Why “low risk” isn’t always low impact

Oliver Bathe, Professor of Surgery and Oncology at the University of Calgary and CEO of Qualisure Diagnostics, urges us to rethink papillary thyroid cancer, noting that “low risk” isn’t always synonymous with low impact.

Follow Us

Advertisements